A study investigates the links between fine-scale populations and outcomes including healthcare use and disease risk in a Los Angeles biobank, unveiling crucial insights into healthcare disparities in the USA.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Caggiano, C. et al. Nat. Med. https://doi.org/10.1038/s41591-023-02425-1 (2023).
The SIGMA Type 2 Diabetes Consortium. Nature 506, 97–101 (2014).
The SIGMA Type 2 Diabetes Consortium. JAMA 311, 2305–2314 (2014).
Jbaily, A. et al. Nature 601, 228–233 (2022).
Martin, A. R. et al. C. Nat. Genet. 51, 584–591 (2019).
Belbin, G. M. et al. Cell 184, 2068–2083.e11 (2021).
Johnson, R. et al. Cell Genom. 3, 100243 (2023).
Vyas, D. A., Eisenstein, L. G. & Jones, D. S. N. Engl. J. Med. 383, 874–882 (2020).
Borrell, L. N. et al. N. Engl. J. Med. 384, 474–480 (2021).
The All of Us Research Program Investigators. N. Engl. J. Med. 381, 668–676 (2019).
Claw, K. G. et al. Nat. Commun. 9, 2957 (2018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Kanai, M. Leveraging fine-scale population structures for precision healthcare. Nat Med 29, 1611–1612 (2023). https://doi.org/10.1038/s41591-023-02423-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02423-3
This article is cited by
-
Building healthy populations
Nature Medicine (2023)